Skip Navigation LinksHome > September 2014 - Volume 24 - Issue 7 > Surgical Principles for Managing Stage IB2, IIA2, and IIB Ut...
International Journal of Gynecological Cancer:
doi: 10.1097/IGC.0000000000000202
Cervical Cancer

Surgical Principles for Managing Stage IB2, IIA2, and IIB Uterine Cervical Cancer (Bulky Tumors) in Japan: A Survey of the Japanese Gynecologic Oncology Group

Mikami, Mikio MD, PhD*; Aoki, Yoichi MD, PhD; Sakamoto, Masaru MD, PhD; Shimada, Muneaki MD, PhD§; Takeshima, Nobuhiro MD, PhD; Fujiwara, Hisaya MD, PhD; Matsumoto, Takashi MD, PhD#; Kita, Tunekazu MD, PhD**; Takizawa, Ken MD, PhD; Disease Committee of Uterine Cervical and Vulvar Cancer, Japanese Gynecologic Oncology Group

Collapse Box


Objective: The aim of this study was to determine the current operative management of International Federation of Gynecology and Obstetrics (FIGO) stage IB2, IIA2, and IIB uterine cervical cancer (bulky tumors) in Japan by surveying the member institutions of the Japanese Gynecologic Oncology Group.

Methods: We conducted a survey to assess current operative management, including indications and treatment, at all 199 active member institutions of the Japanese Gynecologic Oncology Group.

Results: A total of 166 institutions (83.4%) responded to the survey. For patients with stage IIB squamous cell carcinoma, 35.5% (59/166) of the institutions performed surgery. For stage IIB nonsquamous cell carcinoma, surgery was performed at 88 (53.7%) of 164 institutions. Neoadjuvant chemotherapy was provided by 75 (45.5%) of 165 institutions (actively in 44 and reluctantly in 31). At 101 (61.2%) of 165 institutions, para-aortic node dissection was performed as part of radical surgery in patients with any indications. At 96 (57.9%) of 166 institutions, high-risk patients underwent chemoradiotherapy after surgery. On the other hand, adjuvant chemotherapy was given to high-risk and intermediate-risk patients at 19.9% and 33.1% institutions, respectively. More than half of the 166 institutions considered the number of metastatic nodes (91/166, 54.8%) and tumor histology (116/166, 69.9%) when selecting adjuvant therapy.

Conclusions: This survey provided information regarding the current surgical management of uterine cervical cancer (stages IB2, IIA2, and IIA) in Japan.

© 2014 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.